Mazzulli T, Rusconi S, Merrill DP, D’Aquila RT, Moonis M, Chou TC, and Hirsch MS. Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitro. Antimicrob Agents Chemother, 1994, 38:656-661.
Rusconi S, Merrill DP, and Hirsch MS. Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy. J Infect Dis, 1994, 170:1361-1366.
Wilson CC, Wong JT, Girard DD, Merrill DP, Dynan M, An DD, Kalams SA, Johnson RP, Hirsch MS, D’Aquila RT, and Walker BD. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis, 1995, 172:88-96.
Merrill DP, Moonis M, Chou TC, and Hirsch MS. Lamivudine (3TC) or starudine (d4T) in two and three-drug combinations against HIV-1 replication in vitro. J Infect Dis, 1996; 173: 355-364